SMTL ID : 3da6.1

Crystal Structure of human JNK3 complexed with N-(3-methyl-4-(3-(2-(methylamino)pyrimidin-4-yl)pyridin-2-yloxy)naphthalen-1-yl)-1H-benzo[d]imidazol-2-amine

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x BZ9: N-[3-methyl-4-({3-[2-(methylamino)pyrimidin-4-yl]pyridin-2-yl}oxy)naphthalen-1-yl]-1H-benzimidazol-2-amine(Non-covalent)

BZ9.1: 19 residues within 4Å: Chain A: I.32, G.33, S.34, V.40, A.53, K.55, L.57, A.70, E.73, M.77, I.86, L.106, M.108, E.109, L.110, M.111, S.155, N.156, L.168 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:I.32, A:V.40, A:A.53, A:K.55, A:L.57, A:L.57, A:E.73, A:I.86, A:L.106, A:L.106, A:L.168, A:L.168 Hydrogen bonds: A:K.55, A:K.55, A:M.111, A:M.111, A:L.168 pi-Cation interactions: A:K.55

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cee, V.J. et al., Pyridyl-pyrimidine benzimidazole derivatives as potent, selective, and orally bioavailable inhibitors of Tie-2 kinase. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-01-06

Peptides

Mitogen-activated protein kinase 10: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 10

Related Entries With Identical Sequence